Literature DB >> 20683664

The prevalence of evidence-based drug use prevention curricula in U.S. middle schools in 2008.

Chris Ringwalt1, Amy A Vincus, Sean Hanley, Susan T Ennett, J Michael Bowling, Susan Haws.   

Abstract

The No Child Left Behind Act mandates the implementation of evidence-based drug prevention curricula in the nation's schools. The purpose of this paper is to estimate changes in the prevalence of such curricula from 2005 to 2008. We surveyed school staff in a nationally representative sample of schools with middle school grades. Using a web-based approach to data collection that we supplemented by telephone calls, we secured data from 1892 schools for a response rate of 78.2%. We estimate that the prevalence of evidence-based drug prevention curricula rose from 42.6% in 2005 to 46.9% in 2008, and that the prevalence of schools that used these curricula most frequently increased from 22.7% to 25.9% over this period. In addition, the proportion of schools using locally developed curricula also rose, from 17.6% to 28.1%. This study suggests the success of efforts by the Office of Safe and Drug-Free Schools to increase the prevalence of evidence-based curricula, as well as the need to continue to track the prevalence of these curricula in response to any reductions in the Office's fiscal support for evidence-based drug prevention curricula in the nation's schools.

Entities:  

Mesh:

Year:  2011        PMID: 20683664      PMCID: PMC3032820          DOI: 10.1007/s11121-010-0184-3

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  7 in total

1.  The prevalence of effective substance use prevention curricula in U.S. middle schools.

Authors:  Christopher L Ringwalt; Susan Ennett; Amy Vincus; Judy Thorne; Louise Ann Rohrbach; Ashley Simons-Rudolph
Journal:  Prev Sci       Date:  2002-12

2.  Results of an independent evaluation of Project ALERT delivered in schools by Cooperative Extension.

Authors:  Tena L St Pierre; D Wayne Osgood; Claudia C Mincemoyer; D Lynne Kaltreider; Tina J Kauh
Journal:  Prev Sci       Date:  2005-12

3.  The devil is in the details: examining the evidence for "proven" school-based drug abuse prevention programs.

Authors:  Allison Gruner Gandhi; Erin Murphy-Graham; Anthony Petrosino; Sara Schwartz Chrismer; Carol H Weiss
Journal:  Eval Rev       Date:  2007-02

4.  The social construction of "evidence-based'' drug prevention programs: a reanalysis of data from the Drug Abuse Resistance Education (DARE) program.

Authors:  Dennis M Gorman; J Charles Huber
Journal:  Eval Rev       Date:  2009-04-21

5.  The effects of Project ALERT one year past curriculum completion.

Authors:  Chris L Ringwalt; Heddy Kovach Clark; Sean Hanley; Stephen R Shamblen; Robert L Flewelling
Journal:  Prev Sci       Date:  2010-06

6.  Project ALERT: a cluster randomized trial.

Authors:  Christopher L Ringwalt; Heddy Kovach Clark; Sean Hanley; Stephen R Shamblen; Robert L Flewelling
Journal:  Arch Pediatr Adolesc Med       Date:  2009-07

7.  The prevalence of evidence-based drug use prevention curricula in U.S. middle schools in 2005.

Authors:  Chris Ringwalt; Amy A Vincus; Sean Hanley; Susan T Ennett; J Michael Bowling; Louise Ann Rohrbach
Journal:  Prev Sci       Date:  2009-03
  7 in total
  15 in total

1.  The effects of No Child Left Behind on the prevalence of evidence-based drug prevention curricula in the nation's middle schools.

Authors:  Chris Ringwalt; Sean Hanley; Susan T Ennett; Amy A Vincus; J Michael Bowling; Susan W Haws; Louise A Rohrbach
Journal:  J Sch Health       Date:  2011-05       Impact factor: 2.118

2.  Describing teacher-student interactions: a qualitative assessment of teacher implementation of the 7th grade keepin' it REAL substance use intervention.

Authors:  Jonathan Pettigrew; Michelle Miller-Day; Youngju Shin; Michael L Hecht; Janice L Krieger; John W Graham
Journal:  Am J Community Psychol       Date:  2013-03

3.  Evidence-based practice in school substance use prevention: fidelity of implementation under real-world conditions.

Authors:  S T Ennett; S Haws; C L Ringwalt; A A Vincus; S Hanley; J M Bowling; L A Rohrbach
Journal:  Health Educ Res       Date:  2011-03-07

4.  Adherence and delivery: implementation quality and program outcomes for the seventh-grade keepin' it REAL program.

Authors:  Jonathan Pettigrew; John W Graham; Michelle Miller-Day; Michael L Hecht; Janice L Krieger; Young Ju Shin
Journal:  Prev Sci       Date:  2015-01

5.  Effects of Communities That Care on the adoption and implementation fidelity of evidence-based prevention programs in communities: results from a randomized controlled trial.

Authors:  Abigail A Fagan; Michael W Arthur; Koren Hanson; John S Briney; J David Hawkins
Journal:  Prev Sci       Date:  2011-09

6.  Effects of Communities That Care on Males' and Females' Drug Use and Delinquency 9 Years After Baseline in a Community-Randomized Trial.

Authors:  Sabrina Oesterle; J David Hawkins; Margaret R Kuklinski; Abigail A Fagan; Christopher Fleming; Isaac C Rhew; Eric C Brown; Robert D Abbott; Richard F Catalano
Journal:  Am J Community Psychol       Date:  2015-12

7.  Sustaining the utilization and high quality implementation of tested and effective prevention programs using the communities that care prevention system.

Authors:  Abigail A Fagan; Koren Hanson; John S Briney; J David Hawkins
Journal:  Am J Community Psychol       Date:  2012-06

8.  Lifetime Cost of Abusive Head Trauma at Ages 0-4, USA.

Authors:  Ted R Miller; Ryan Steinbeigle; Bruce A Lawrence; Cora Peterson; Curtis Florence; Marilyn Barr; Ronald G Barr
Journal:  Prev Sci       Date:  2018-08

9.  Assessing Sustained Effects of Communities That Care on Youth Protective Factors.

Authors:  B K Elizabeth Kim; Sabrina Oesterle; J David Hawkins; Valerie B Shapiro
Journal:  J Soc Social Work Res       Date:  2015-10-06

10.  Examining the association between implementation and outcomes : state-wide scale-up of school-wide positive behavior intervention and supports.

Authors:  Elise T Pas; Catherine P Bradshaw
Journal:  J Behav Health Serv Res       Date:  2012-10       Impact factor: 1.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.